CTLA4 and cancer: Co-inhibitory receptors on T cell surfaces called cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed cell death 1 (PD-1) help to reduce T cell-mediated immune responses; however, cancer cells use these inhibitory molecules to encourage tumor tolerance and T cell exhaustion [139,140].